Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in the Liver

Clinical trial NCT03472586 · COMPLETED

Trial details

NCT number: NCT03472586
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Liver Metastatic Uveal Melanoma Stage IV Uveal Melanoma AJCC v7

Start date: 2018-05-02
Primary completion: 2022-12-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.